Smartleaf Asset Management LLC Buys 160 Shares of McKesson Co. (NYSE:MCK)

Smartleaf Asset Management LLC grew its stake in shares of McKesson Co. (NYSE:MCK) by 13.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,389 shares of the company’s stock after buying an additional 160 shares during the period. Smartleaf Asset Management LLC’s holdings in McKesson were worth $793,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Maia Wealth LLC bought a new stake in shares of McKesson during the fourth quarter valued at approximately $241,000. Hickory Point Bank & Trust bought a new stake in shares of McKesson during the fourth quarter valued at approximately $342,000. Providence First Trust Co raised its position in shares of McKesson by 0.8% during the fourth quarter. Providence First Trust Co now owns 3,288 shares of the company’s stock valued at $1,874,000 after buying an additional 26 shares during the last quarter. US Bancorp DE raised its position in shares of McKesson by 0.8% during the fourth quarter. US Bancorp DE now owns 88,835 shares of the company’s stock valued at $50,629,000 after buying an additional 684 shares during the last quarter. Finally, SVB Wealth LLC purchased a new position in shares of McKesson in the fourth quarter valued at $2,137,000. Institutional investors own 85.07% of the company’s stock.

McKesson Trading Up 0.8 %

Shares of MCK opened at $645.34 on Tuesday. The firm has a market capitalization of $80.88 billion, a P/E ratio of 29.55, a P/E/G ratio of 1.29 and a beta of 0.52. McKesson Co. has a 12-month low of $464.42 and a 12-month high of $648.47. The firm has a fifty day moving average price of $595.50 and a 200-day moving average price of $564.96.

McKesson (NYSE:MCK) last issued its earnings results on Wednesday, February 5th. The company reported $8.03 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $8.60 by ($0.57). McKesson had a net margin of 0.82% and a negative return on equity of 181.26%. Analysts predict that McKesson Co. will post 32.77 earnings per share for the current year.

McKesson Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, April 1st. Stockholders of record on Monday, March 3rd will be paid a dividend of $0.71 per share. This represents a $2.84 dividend on an annualized basis and a dividend yield of 0.44%. The ex-dividend date is Monday, March 3rd. McKesson’s dividend payout ratio is currently 13.00%.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on MCK. Morgan Stanley raised their target price on shares of McKesson from $612.00 to $642.00 and gave the company an “overweight” rating in a report on Tuesday, December 17th. StockNews.com lowered shares of McKesson from a “strong-buy” rating to a “buy” rating in a report on Friday, February 14th. Robert W. Baird raised shares of McKesson from a “neutral” rating to an “outperform” rating and raised their target price for the company from $531.00 to $688.00 in a report on Thursday, November 7th. Citigroup cut their target price on shares of McKesson from $713.00 to $677.00 and set a “buy” rating for the company in a report on Friday, January 10th. Finally, Baird R W raised shares of McKesson from a “hold” rating to a “strong-buy” rating in a report on Thursday, November 7th. Two investment analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, McKesson presently has an average rating of “Moderate Buy” and a consensus price target of $645.79.

Insider Activity

In other news, EVP Leann B. Smith sold 579 shares of the business’s stock in a transaction on Monday, December 9th. The shares were sold at an average price of $602.81, for a total transaction of $349,026.99. Following the completion of the sale, the executive vice president now directly owns 1,443 shares of the company’s stock, valued at approximately $869,854.83. The trade was a 28.64 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Brian S. Tyler sold 8,961 shares of McKesson stock in a transaction dated Friday, February 21st. The shares were sold at an average price of $597.99, for a total value of $5,358,588.39. Following the completion of the sale, the chief executive officer now owns 60,664 shares of the company’s stock, valued at $36,276,465.36. The trade was a 12.87 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 19,268 shares of company stock valued at $11,536,378. 0.11% of the stock is currently owned by company insiders.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.